Raymond James & Associates’s BlackRock Health Sciences Trust BME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $1.91M | Buy |
|
|||||
|
2024
Q2 | $1.83M | Buy |
|
|||||
|
2024
Q1 | $1.74M | Buy |
|
|||||
|
2023
Q4 | $1.65M | Buy |
|
|||||
|
2023
Q3 | $1.54M | Buy |
|
|||||
|
2023
Q2 | $1.57M | Buy |
|
|||||
|
2023
Q1 | $1.58M | Buy |
|
|||||
|
2022
Q4 | $1.61M | Buy |
|
|||||
|
2022
Q3 | $1.42M | Buy |
|
|||||
|
2022
Q2 | $1.55M | Sell |
|
|||||
|
2022
Q1 | $1.66M | Buy |
|
|||||
|
2021
Q4 | $1.71M | Buy |
|
|||||
|
2021
Q3 | $1.26M | Buy |
|
|||||
|
2021
Q2 | $1.24M | Buy |
|
|||||
|
2021
Q1 | $1.02M | Buy |
|
|||||
|
2020
Q4 | $818K | Sell |
|
|||||
|
2020
Q3 | $756K | Buy |
|
|||||
|
2020
Q2 | $708K | Sell |
|
|||||
|
2020
Q1 | $768K | Buy |
|
|||||
|
2019
Q4 | $854K | Buy |
|
|||||
|
2019
Q3 | $724K | Buy |
|
|||||
|
2019
Q2 | $709K | Sell |
|
|||||
|
2019
Q1 | $782K | Sell |
|
|||||
|
2018
Q4 | $843K | Buy |
|
|||||
|
2018
Q3 | $972K | Buy |
|
|||||
|
2018
Q2 | $533K | Buy |
|
|||||
|
2018
Q1 | $473K | Sell |
|
|||||
|
2017
Q4 | $517K | Hold |
|
|||||
|
2017
Q3 | $517K | Buy |
|
|||||
|
2017
Q2 | $492K | Buy |
|
|||||
|
2017
Q1 | $409K | Buy |
|
|||||
|
2016
Q4 | $367K | Buy |
|
|||||
|
2016
Q3 | $294K | Buy |
|
|||||
|
2016
Q2 | $278K | Buy |
|
|||||
|
2016
Q1 | $259K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $446K | Buy |
|